title: Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate.
authors.forename: Naoto
authors.initials: N
authors.lastname: Takahashi
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kameoka
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Tagawa
authors.forename: Hirobumi
authors.initials: H
authors.lastname: Saitoh
authors.forename: Tomoko
authors.initials: T
authors.lastname: Yoshioka
authors.forename: Naohito
authors.initials: N
authors.lastname: Fujishima
authors.forename: Atsushi
authors.initials: A
authors.lastname: Kitabayashi
authors.forename: Kaoru
authors.initials: K
authors.lastname: Takahashi
authors.forename: Makoto
authors.initials: M
authors.lastname: Hirokawa
authors.forename: Kenichi
authors.initials: K
authors.lastname: Sawada
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D020732:Cytogenetic Analysis; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects / Q000473:pathology*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate